Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Arsenal Growth Equity is a U.S.-based growth equity and venture investor focused primarily on software and tech-enabled companies rather than a drug-development biotech, pharma, or healthcare operating company. The firm invests in high-growth businesses across sectors including enterprise software, cybersecurity, compliance, commerce, fintech, and digital health. Its model is to provide growth capital to recurring-revenue companies and partner with management teams to scale operations and build enterprise value. While Arsenal Growth has exposure to digital health and healthcare IT, it does not appear to operate a therapeutic pipeline, drug platform, or life sciences R&D organization itself.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Arsenal Growth Equity.